News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
3 days left to submit your abstracts for Hot Topic in Basic and Translational Science 2024 – IASLC
Photo taken from IASLC/X
Jul 31, 2024, 06:23

3 days left to submit your abstracts for Hot Topic in Basic and Translational Science 2024 – IASLC

IASLC (International Association for the Study of Lung Cancer) shared a post on X:

“Only 3 days left to submit your abstracts for Hot Topic in Basic and Translational Science 2024! Submission closes on 7/31 midnight.

Share your groundbreaking research and contribute to the future of lung cancer therapy, and our understanding/treatment of drug tolerance and resistance in NSCLC.”

Source: IASLC/X

cancer IASLC Lung cancer NSCLC OncoDaily Oncology
Special Coverage
Insight
Dec 22, 2024, 11:22
Omar Alhalabi: Antiangiogenesis and immune checkpoint blockade in urothelial cancer
Blog
Dec 22, 2024, 10:51
Gemma Peters: Heading into 2025 with hope
Science
Dec 22, 2024, 10:44
5 papers about Lung Cancer suggested by Stephen Liu
Science
Dec 22, 2024, 10:15
Dégi László Csaba: Thrilled to announce the new Lancet Oncology Policy Review analyzing NCCPs worldwide
Science
Dec 22, 2024, 10:13
Denis Horgan: Delayed Access to Personalized Medicine in the EU - What’s the Cost to Patients?
Blog
Dec 22, 2024, 10:12
Emad Shash: Honor to be among the newly elected council of the Egyptian Cancer Society
Science
Dec 22, 2024, 10:03
María Natalia Gandur Quiroga: Checkpoint inhibitors and Fc functions - key findings in oncology immunotherapy
Science
Dec 22, 2024, 10:00
Francesco Maura: CD38 loss as mechanisms of resistance to anti-CD38 MoAb in myeloma
Science
Dec 22, 2024, 09:59
CDK4/6 inhibitors: mechanisms of resistance and where to find them - Lorenzo Gerratana
Blog
Dec 22, 2024, 09:53
India's Oncology Testing Market Projected to Grow at 2% CAGR Through 2033: GlobalData
Dialogues
Dec 22, 2024, 09:40
Botensilimab: A Novel Anti-CTLA- 4 Therapy Effectively Treats Refractory Colorectal Cancers
Dialogues
Dec 22, 2024, 09:04
Carlos Rodriguez-Galindo: The Man Who Will Cure the World